Abstract Details

Title Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Safe and Effective?

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P5 - (-)

Poster/Presentation
Number 239

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Francis M. Gengo, PharmD (Dent Neurologic Institute) PRESENTER	No disclosure on file
Erica S. Westphal (Dent Neurologic Institute)	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Traci Aladeen, PharmD (Dent Neurologic Institute)	Dr. Aladeen has nothing to disclose.
	No disclosure on file
Michelle Rainka, PharmD (Dent Neurologic Institute)	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Vernice E. Bates, MD (Dent Neurologic Institute)	No disclosure on file